SIMULATION MODEL OF IBRUTINIB IN TREATMENT OF RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA (MCL)

被引：3
|
作者：
Peng, S. [1 ]
Sorensen, S. [1 ]
Pan, F. [1 ]
Dorman, E. [1 ]
Sun, S. [2 ]
Van Sanden, S. [3 ]
Sengupta, N. [4 ]
Gaudig, M. [5 ]
机构：
[1] Evidera, Bethesda, MD USA
[2] Janssen, Raritan, NJ USA
[3] Univ Hosp Leuven, Leuven, Belgium
[4] Janssen Pharmaceut Inc, Raritan, NJ USA
[5] Janssen Pharmaceut Inc, Neuss, Germany
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2196
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN38
引用
收藏
页码：A620 / A620
页数：1
相关论文
共 50 条
  • [21] A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma
    Qualls, David
    Lam, Hiu Ying
    Whiting, Karissa
    Kumar, Anita
    Matasar, Matthew
    Owens, Colette
    Nichols, Chelsea
    Espeleta, James A.
    Qiu, Annie
    Subzwari, Sarima
    Biggar, Erin
    Seshan, Venkatraman
    Salles, Gilles
    Younes, Anas
    Batlevi, Connie
    BLOOD ADVANCES, 2022, 6 (18) : 5262 - 5266
  • [22] Bortezomib in relapsed or refractory mantle cell lymphoma (MCL): Results of the PINNACLE study.
    Goy, A.
    Bernstein, S. H.
    Kahl, B. S.
    Djulbegovic, B.
    Robertson, M. J.
    Boral, A.
    Shi, H.
    Fisher, R. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 425S - 425S
  • [23] Frequency of Gastrointestinal Involvement and Endoscopy Findings in Refractory/Relapsed Mantle Cell Lymphoma (MCL)
    Shafi, Mehnaz A.
    Barrientos, Ryan
    GASTROENTEROLOGY, 2011, 140 (05) : S875 - S876
  • [24] IBRORS-MCL Study: A Spanish Retrospective and Observational Study of Relapsed/Refractory Mantle-Cell Lymphoma (MCL) Treated with Ibrutinib in Routine Clinical Practice
    Manuel Sancho, Juan
    Marin, Ana
    Fernandez, Silvia
    Javier Capote, Francisco
    Canigral, Carolina
    Grande, Carlos
    Donato, Eva
    Zeberio, Izaskun
    Manuel Puerta, Jose
    Rivas, Alfredo
    Perez Ceballos, Elena
    Vale, Ana
    Martin, Alejandro
    Salar, Antonio
    Gonzalez Barca, Eva
    Teruel, Anabel
    Pastoriza, Carmen
    Conde Royo, Diego
    Sanchez, Joaquin
    Barrenetxea, Cristina
    Arranz, Reyes
    Hernandez Rivas, Jose Angel
    Ramirez, Josefa
    Jimenez, Aroa
    Loriente, Cristina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S258 - S259
  • [25] Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL).
    Batlevi, Connie Lee
    Hamlin, Paul A.
    Matasar, Matthew J.
    Horwitz, Steven M.
    Gerecitano, John F.
    Moskowitz, Craig H.
    Straus, David J.
    Zelenetz, Andrew David
    Drullinsky, Pamela
    Copeland, Amanda
    Ahsanuddin, Salma
    Callan, Devin
    Freidin, Benjamin
    Porzio, Robert
    Dang, Thu Oanh
    Ni, Ai
    Rademaker, Jurgen
    Schoder, Heiko
    Dogan, Ahmet
    Younes, Anas
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
    Maddocks, Kami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S187 - S188
  • [27] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [28] Evaluating pirtobrutinib for the treatment of relapsed or refractory mantle cell lymphoma
    Wang, Jacqueline F.
    Wang, Yucai
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (10) : 651 - 659
  • [29] Treatment Patterns and Outcomes in Relapsed/Refractory Mantle Cell Lymphoma
    Tawfiq, Reema K.
    Larson, Melissa C.
    Gile, Jennifer Jane
    Bock, Allison M.
    Poonsombudlert, Kittika
    Maliske, Seth M.
    Maurer, Matthew J.
    Cerhan, James R.
    Kabat, Brian
    Smith, Katherine
    Godby, Richard Curtis
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Wang, Yucai
    BLOOD, 2022, 140 : 6489 - 6491
  • [30] Ibrutinib for the treatment of mantle cell lymphoma
    Shah, Nimish
    Hutchinson, Claire
    Rule, Simon
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (05) : 521 - 531
12345